Accelovance
16
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.3%
1 terminated/withdrawn out of 16 trials
93.3%
+6.8% vs industry average
13%
2 trials in Phase 3/4
36%
5 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia Patients
Role: collaborator
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)
Role: collaborator
Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients
Role: collaborator
A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma
Role: collaborator
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Role: collaborator
Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Role: collaborator
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
Role: collaborator
Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
Role: collaborator
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
Role: collaborator
Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores
Role: collaborator
Intracutaneous Delivery of Varied Dose Volumes of Saline
Role: collaborator
Site Selection for Intracutaneous Saline Delivery
Role: collaborator
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
Role: collaborator
Growth of Healthy Term Infants Fed Formula Containing DHA-B
Role: collaborator
Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years
Role: collaborator
A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001
Role: collaborator
All 16 trials loaded